Suchergebnisse - "Burhenne, Jürgen"

PubPharm (529)

1

Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers

enthalten in: Clinical pharmacokinetics | 2024

von Rohr, B. | Krohmer, E. | Foerster, K. | +5

2

Extracellular Vesicles as Surrogates for the Regulation of the Drug Transporters ABCC2 (MRP2) and ABCG2 (BCRP)

enthalten in: International journal of molecular sciences | 2024

von Rigalli, J. | Gagliardi, A. | Diester, K. | +11

3

RNA is a pro-apoptotic target of cisplatin in cancer cell lines and C. elegans

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2024

von Rose, F. | Köberle, B. | Honnen, S. | +5

4

In vitro evaluation of the reductive carbonyl idarubicin metabolism to evaluate inhibitors of the formation of cardiotoxic idarubicinol via carbonyl and aldo-keto reductases

enthalten in: Archives of toxicology | 2024

von Bajraktari-Sylejmani, G. | Oster, J. | Burhenne, J. | +3

5

Effect of Tacrolimus Formulation (Prolonged-Release vs Immediate-Release) on Its Susceptibility to Drug-Drug Interactions with St. John's Wort

enthalten in: Clinical pharmacology in drug development | 2024

von Gümüs, K. | Teegelbekkers, A. | Sauter, M. | +6

6

Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers

enthalten in: Clinical pharmacokinetics | 2024

von Rohr, B. | Krohmer, E. | Foerster, K. | +5

7

Feasibility and Safety of Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia (SANE-01) : A Randomized, Double-blind, Placebo-controlled Phase Ib Clinical Trial

enthalten in: The Journal of pediatrics | 2024

von Wintermark, P. | Lapointe, A. | Steinhorn, R. | +15

8

Burden of intracerebral haemorrhage in Europe : forecasting incidence and mortality between 2019 and 2050

enthalten in: The Lancet regional health. Europe | 2024

von Wafa, H. | Marshall, I. | Wolfe, C. | +72

9

Therapeutic drug monitoring of osimertinib in non-small cell lung cancer and short bowel syndrome : A case report

enthalten in: British journal of clinical pharmacology | 2024

von Longuespée, R. | Kunz, J. | Fresnais, M. | +7

10

Evaluation of Hydroxychloroquine as a Perpetrator on Cytochrome P450 (CYP) 3A and CYP2D6 Activity with Microdosed Probe Drugs in Healthy Volunteers

enthalten in: European journal of drug metabolism and pharmacokinetics | 2024

von Stoll, F. | Blank, A. | Mikus, G. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[53]